Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 24, 2018
April 22, 2020
42e7890d-c6f4-4da5-839f-438c6dc2dcf4
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Complicated Intra-Abdominal Infections: Developing Drugs for Treatment
Guidance DocumentMay 1, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox